Evidence map›Paper›PMID 40775086›Full record

ArticleNature methods2025

Ultra-high-scale cytometry-based cellular interaction mapping.

Dominik Vonficht, Lea Jopp-Saile, Schayan Yousefian, Viktoria Flore, Inés Simó Vesperinas, Ruth Teuber, Bogdan Avanesyan, Yanjiang Luo, Caroline Röthemeier, Florian Grünschläger and 20 more

Abstract read
In one paragraph

Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Decoding Immune Cell Doublets in Humans: From Artifacts to Insights.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2026
    Review
  3. Article
  4. Article
  5. Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Dominik Vonficht *Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Lea Jopp-Saile *Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Schayan Yousefian *Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-0902-0369
Viktoria Flore *Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0001-3023-433X
Inés Simó VesperinasBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.
Ruth TeuberBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.
Bogdan AvanesyanBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0004-2547-6598
Yanjiang LuoDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0003-0401-467X
Caroline RöthemeierBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.
Florian GrünschlägerHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0021-6912
Mirian Fernandez-VaqueroFaculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Vincent FregonaBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.
Diana Ordoñez-RuedaFlow Cytometry Core Facility, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8387-6707
Laura K SchmalbrockBerlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-6080-6175
Luca DeiningerInstitute for Automation and Applied Informatics, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany.ORCID http://orcid.org/0009-0005-5125-6422
Angelo Jovin Yamachui SitcheuInstitute for Automation and Applied Informatics, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany.ORCID http://orcid.org/0009-0002-9384-6496
Zuguang GuComputational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center, Heidelberg, Germany.
Maja C FunkInstitute of Lung Health and Immunity, Comprehensive Pneumology Center Munich, Helmholtz Zentrum München, Munich, Germany, German Center for Lung Research (DZL), Munich, Germany.ORCID http://orcid.org/0000-0002-6007-1164
Ralf MikutInstitute for Automation and Applied Informatics, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany.ORCID http://orcid.org/0000-0001-9100-5496
Mathias HeikenwälderDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Angelika EggertGerman Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arend von StackelbergDepartment of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Sebastian KoboldGerman Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5612-4673
Jan KrönkeDepartment of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ulrich KellerDepartment of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-8485-1958
Andreas TrumppHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Ahmed N HegazyDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Cornelia EckertGerman Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-1039-2872
Daniel HübschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.ORCID http://orcid.org/0000-0002-6041-7049
Simon HaasHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. simon.haas@bih-charite.de.ORCID http://orcid.org/0000-0001-9227-2051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular interactions are of fundamental importance, orchestrating organismal development, tissue homeostasis and immunity. Recently, powerful methods that use single-cell genomic technologies to dissect physically interacting cells have been developed. However, these approaches are characterized by low cellular throughput, long processing times and high costs and are typically restricted to predefined cell types. Here we introduce Interact-omics, a cytometry-based framework to accurately map cellular landscapes and cellular interactions across all immune cell types at ultra-high resolution and scale. We demonstrate the utility of our approach to study kinetics, mode of action and personalized response prediction of immunotherapies, and organism-wide shifts in cellular composition and cellular interaction dynamics following infection in vivo. Our scalable framework can be applied a posteriori to existing cytometry datasets or incorporated into newly designed cytometry-based studies to map cellular interactions with a broad range of applications from fundamental biology to applied biomedicine.

Indexed as

Cell CommunicationFlow CytometrySingle-Cell AnalysisAnimalsHumansMice

Identifiers

PMID40775086
PMCPMC12446065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.